Cincinnati Children’s Hospital Medical Center


Cincinnati Children’s Hospital Conducting Phase I/II Clinical Trial Investigating BNT 162 COVID-19 Vaccine

Representing one of four sites across the United States, principal investigator and former Naval Officer Dr. Robert Frenck at Cincinnati Children’s Hospital is leading the Phase I/2 trials investigating the BNT 162 COVID-19 vaccine. Developed by a German biotech...

Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...

Pin It on Pinterest